BioSpace News Archive

Drug Development

Seattle Genetics, Inc. Announces Phase IIb Trial of Lintuzumab (SGN-33) in Patients with Acute Myeloid Leukemia (AML) Did Not Meet Primary Endpoint; Has Decided to Put Drug on the Shelf

September 13, 2010
·
5 min read
BioCapital

FDA Mulls Removing Abbott Laboratories Weight-Loss Drug Meridia from US Market

September 13, 2010
·
1 min read
Golimumab Eases Sleep in Ankylosing Spondylitis

September 13, 2010
·
1 min read
BioMidwest

Allos Therapeutics, Inc. to Present at Upcoming Investor Conferences

September 13, 2010
·
1 min read
Deals

Otix Global, Inc. Enters Into Definitive Merger Agreement With William Demant Holding A/S

September 13, 2010
·
3 min read
Bio NC

Metabolon Awarded US Patent for Determining Metabolic Age of an Individual

September 13, 2010
·
1 min read
Business

Lannett Company, Inc. Reports Fiscal 2010 Fourth Quarter, Full Year Financial Results

September 13, 2010
·
1 min read
Drug Development

Spaulding Clinical Research to Perform Bioequivalence Study for One of World’s Largest Pharmaceutical Companies

September 13, 2010
·
1 min read
BioMidwest

New Data from Enlyten Medical Technologies Supports Use of an Antigen-Directed, Cancer-Specific Targeting Agent for PET-Based Imaging

September 13, 2010
·
1 min read
Business

Unprecedented Health, Education and Philanthropy Collaboration Charts New Future for Charles R. Drew University of Medicine and Science

September 13, 2010
·
1 min read